Top Markets
Coin of the day
XORTX Therapeutics Inc. XORTX Therapeutics Inc.

XORTX Therapeutics Inc.

XRTX
Classificação em ações #39280
Based in Vancouver, Canada, XORTX Therapeutics Inc. is a biopharmaceutical firm... Based in Vancouver, Canada, XORTX Therapeutics Inc. is a biopharmaceutical firm dedicated to discovering and bringing to market treatments for a variety of conditions, including progressive kidney disorders, diabetes, insulin resistance, metabolic syndrome, and infections. The company's pipeline includes XRx-008, a late-stage clinical program addressing autosomal dominant polycystic kidney disease; XRx-101, an agent designed to reduce uric acid levels in COVID-19 patients to prevent acute kidney injury and its associated health issues; and XRx-221, a series of xanthine oxidase inhibitor candidates aimed at treating diabetic nephropathy. Furthermore, XORTX Therapeutics collaborates with the Icahn School of Medicine to research the occurrence of acute kidney injury and elevated uric acid in patients hospitalized with COVID-19.
Preço da ação
$2.06
Última sincronização: 2026-08-11
Valor de mercado
$572.30K
Variação (1 dia)
0.00%
Variação (1 ano)
-90.38%
País
CA
Negociar XORTX Therapeutics Inc. (XRTX)

Categoria

Histórico de preços das ações de XORTX Therapeutics Inc. (XRTX)
Preço de fecho mais alto: $2.06 em 2026-08-01

Preço de fecho mais baixo: $173.60 em 2015-10-01
Histórico de preços das ações da XORTX Therapeutics Inc. de 2015 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) -27.44%
2025 -48.32%
2024 -50.05%
2023 -69.00%
2022 -58.91%
2021 105.10%
2020 -34.17%
2019 8.63%
2018 152.77%
2017 -20.67%
2016 22.14%
2015 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
$517.18 32.51%
US
$857.76 31.47%
NL
$728.31 6.63%
CH
$1.07K -6.40%
KR
$254.43 12.40%
BE